Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

PRVB

Provention Bio (PRVB)

Provention Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRVB
DateHeureSourceTitreSymboleSociété
08/05/202322h18Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:PRVBProvention Bio Inc
01/05/202312h20Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRVBProvention Bio Inc
28/04/202322h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRVBProvention Bio Inc
28/04/202300h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRVBProvention Bio Inc
27/04/202323h01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRVBProvention Bio Inc
27/04/202322h49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRVBProvention Bio Inc
27/04/202315h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRVBProvention Bio Inc
27/04/202314h37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PRVBProvention Bio Inc
19/04/202323h11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRVBProvention Bio Inc
29/03/202323h10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRVBProvention Bio Inc
24/03/202312h53Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PRVBProvention Bio Inc
24/03/202312h11Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PRVBProvention Bio Inc
24/03/202311h05Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PRVBProvention Bio Inc
17/03/202321h17Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRVBProvention Bio Inc
13/03/202321h39Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRVBProvention Bio Inc
13/03/202312h00PR Newswire (US)Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference CallNASDAQ:PRVBProvention Bio Inc
03/03/202322h05PR Newswire (US)Provention Bio Announces the Grant of Inducement AwardsNASDAQ:PRVBProvention Bio Inc
23/02/202314h30PR Newswire (US)Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023NASDAQ:PRVBProvention Bio Inc
13/02/202313h30PR Newswire (US)Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi USNASDAQ:PRVBProvention Bio Inc
08/02/202313h30PR Newswire (US)Provention Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:PRVBProvention Bio Inc
02/02/202322h01PR Newswire (US)Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®NASDAQ:PRVBProvention Bio Inc
05/01/202322h01PR Newswire (US)Provention Bio Announces Appointment of Rita Jain, M.D., to Board of DirectorsNASDAQ:PRVBProvention Bio Inc
21/11/202213h35TipRanksProvention Bio (PRVB) Receives a Buy from SVB SecuritiesNASDAQ:PRVBProvention Bio Inc
21/11/202205h15TipRanksSVB Securities Remains a Buy on Provention Bio (PRVB)NASDAQ:PRVBProvention Bio Inc
18/11/202223h55TipRanksChardan Capital Sticks to Their Buy Rating for Provention Bio (PRVB)NASDAQ:PRVBProvention Bio Inc
18/11/202211h09TipRanksProvention Bio (NASDAQ:PRVB) Stock Spikes as Diabetes Drug Gets FDA’s NodNASDAQ:PRVBProvention Bio Inc
18/11/202200h57Dow Jones NewsProvention Bio Up 8% on Diabetes Drug ApprovalNASDAQ:PRVBProvention Bio Inc
18/11/202200h39Dow Jones NewsProvention Bio Gets FDA OK for Diabetes DrugNASDAQ:PRVBProvention Bio Inc
17/11/202223h45PR Newswire (US)TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1DNASDAQ:PRVBProvention Bio Inc
07/11/202204h35TipRanksProvention Bio (PRVB) Gets a Buy from SVB SecuritiesNASDAQ:PRVBProvention Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PRVB